NIH 2013 - Springer

NIH 2013 - Springer

BIOSCICON, INC. 2013 Point-of-Care Technology for Global Health NIH Conference January 2014 A MODEL INSTRUMENT TO MEASURE EFFICACY OF SMALL MOLECULES TO MODIFY METABOLIC KINETICS IN SINGLE CELLS OBTAINED FROM TUMOR TISSUES 9/19/2013 KINETICS OF BIOMARKER DEVELOPMENT 1 FIGHTING CANCER NEEDS INNOVATIONS CANCER IS DESCRIBED AS UNSTOPABLE GROWTH OF

ABNORMAL CELLS WHICH DISTROY NORMAL CELLS AND TISSUE AT POINTS OF ORIGIN, SPREAD AND METASTASES. CANCER IS A FATAL DISEASE KNOWN FROM THE BEGINNING OF THE HISTORY: ALL ATTMEPTS TO CURE THIS DISEASE, WHEN ADVANCED, HAVE FAILED; CONSEQUENTLY, REPROGRAMMING CANCER GROWTH, IF POSSIBLE, IS THE NEW TARGET OF THE OLD FIGHT AGAINST CANCER. 9/19/2013 KINETICS OF BIOMARKER DEVELOPMENT 2 CHEMOTHERAPY IS NOT PERFECT CHEMOTHERAPY IS DESIGNED TO KILL CANCER CELLS WILE PRESERVING NORMAL TISSUES.

CHEMOTHERAPY HAS CYTOCIDAL (OXYGEN RADICALS, ANTIBODIES) AND CYTOSTATIC (ANTI MITOTIC) EFFECTS; NORMAL CELLS CANNOT BE COMPLETELY PROTECTED. BY THEORY, CHEMOTHERAPY AFFECTS A PERCENT OF CANCER CELLS AND CANNOT ELIMINATE THE LAST CELL WHICH CAN GENERATE CANCER REGROWTH. 9/19/2013 KINETICS OF BIOMARKER DEVELOPMENT 3 WHY REPROGRAMMING? NORMAL CELLS ARE PROGRAMMED TO GROW, DIFFERENTIATE, MATURE AND DIE IN A CONTINUUM OF THEIR LIFE, WICH HAS SUPPORTIVE CONTROL BY THE NORMAL BODY

LOGISTICS. CANCER CELLS DO NOT ABIDE TO BODY CONTROLS AND HAVE ABILITY TO ESCAPE ATTACKS FROM THE IMMUNOSURVEILLANCE AND BODY PROTECTIVE CELLS. 9/19/2013 KINETICS OF BIOMARKER DEVELOPMENT 4 IDEA! CHANGING METABOLIC PATHWAYS IN ABNORMAL CELLS COULD CAUSE: PREMATURE APPOPTOSIS (DYING) OR ELIMINATING FACTORS BLOCKING THE RESPONSE TO NORMAL GROWTH CONTROL MECHANISMS, AND

LETING THEM TO CONTROL FURTHER FAITH OF MODIFIED ABNORMAL CELLS 9/19/2013 KINETICS OF BIOMARKER DEVELOPMENT 5 IN VITRO MODEL TO TEST CELL SENSITIVITY TO DRUGS A COMBINATION OF AN OPEN WINDOWS CELL CULTURE CHAMBER, A SYSTEM FOR CONTINUOUS MONITORING/RECORDING OF INTRACELLULAR CHEMICAL REACTION, SPECIMEN SMEARED ON A GLASS WALL OF THE CHAMBER, CHROMOGENIC SUBSTRATE, A LIGHT MICROSCOPE WITH OR WITHOUT PHOTOMETER OR CAMERA TO MEASURE THE ABSORBANCE, IS

MAKING THE MEASUREMENTS POSSIBLE. 9/19/2013 KINETICS OF BIOMARKER DEVELOPMENT 6 STRUCTURE OF THE MODEL TO TEST CELL SENSITIVITY 9/19/2013 KINETICS OF BIOMARKER DEVELOPMENT 7 SINGLE CELL METABOLIC ANALYSIS Nanoparticles buildup indicating the presence,

location, size and power of bioactive molecules inside single cells. Monitoring of this reaction, or its recording as time lapse still images or a video, could be a powerful quantitative method for testing cell sensitivity to drugs and toxins and new drugs development. 9/19/2013 KINETICS OF BIOMARKER DEVELOPMENT 8 FUNCTION OF THE MODEL THE FOLLOWING VIDEO WILL PRESENT HOW THIS MODEL WORKS AND COULD BE USED IN RESEARCH A NORMAL BLOOD IS SMEARED INSIDE THE INCUBATION CHAMBER.

A NORMAL PML IS FOCUSED IN THE CENTER OF A MICROSCOPIC FIELD MYELOPEROXIDASE REACTION IS INITIATED BY INTRODICING APPROPRIATE SUBSTRATS KINETICS OF THE FINAL REACTION PRODUCT DEVELOPMENT IS OBSERVED, RECORDED AND MEASURED 9/19/2013 KINETICS OF BIOMARKER DEVELOPMENT 9 VIDEO - 1982 9/19/2013 KINETICS OF BIOMARKER DEVELOPMENT

10 KINETICS OF CATALYSIS MEASURED BY PRODUCT DEVELOPMENT S, E S+E K1 > K2 9/19/2013 K3 > K4 SEP KINETICS OF BIOMARKER DEVELOPMENT E+P

P*P K5 > K6 11 MANAGEMENT INTRODUCING INHIBITORS AND ACTIVATORS INTO THIS MODEL SYSTEM, IT WAS POSSIBLE TO MODIFY THE REACTION AND TO MEASURE THE EFFECT OF THE NEW MOLECULES TO THE KINETICS OF INTRACELLULAR METABOLISM CONFIRMING THE FEASIBILITY OF THE MODEL TO ENABLE THE MONITORING AND MEASURING THIS EFFECT WAS A SUFFICIENT EVIDENCE TO WARRANT PATENTING THE MODEL FOR THE APPLICATION IN CANCER REPROGAMMING RESEARCH 9/19/2013

KINETICS OF BIOMARKER DEVELOPMENT 12 TESTING NEW MOLECULES TARGETS OF MEDICAL INTEREST BODY ORGANELLE DNK SYSTEM CELL

RNA ORGAN TISSUE ACTIVE PROTEIN 9/19/2013 MOLECULAR FUNCTIONS TO BE TARGETED INHIBITORS K1/K2

K3/K4 K5/K6 ACTIVATORS KINETICS OF BIOMARKER DEVELOPMENT 13 CERVICAL CANCER CHALLENGE TO CONTROL CAP + HIV MARKERS POSITIVE CERVICAL CANCER CELLS 9/19/2013 KINETICS OF BIOMARKER DEVELOPMENT

14 CONTACT Dr. NENAD MARKOVIC BIOSCICON, INC. WWW.BIOSCICON.COM [email protected] Tel. 301.610.9130 9/19/2013

KINETICS OF BIOMARKER DEVELOPMENT 15

Recently Viewed Presentations

  • Chapter 1 - OUR LAWS

    Chapter 1 - OUR LAWS

    Civil law - addresses wrongs done to individuals, Criminal law - addresses wrongs done to society, Procedural law - deals with methods of enforcing legal rights & duties, Substantive law - defines legal rights and duties, Business law - rules...
  • The Research Process

    The Research Process

    Complete web address ©2015HappyEdugator Note Cards Once you have made a source card for a source, you may take notes. If you only have a small amount of information, you may write it on the source card. If you need...
  • Statistical Applications in Biology and Genetics

    Statistical Applications in Biology and Genetics

    Statistical Applications in Biology and Genetics Tian Zheng Wednesday, March 12, 2003 Outline Biological Background Overview of quantitative research area related to genetics Sample project I: Bayesian Regression Analysis with application to Microarray studies Sample project II: BHTA algorithm for...
  • How to Avoid Plagiarism And Document Sources Joan

    How to Avoid Plagiarism And Document Sources Joan

    Improper: "Although both show obscurity in their poetry, Niedecker's style is much different than Dickinson's" (Johnson 11). This does not quote the source word for word, so it should not be in quotation marks. * * Summary Proper: Lorine Niedecker...
  • Chapter 5 Literary Analysis - Lindy Conner

    Chapter 5 Literary Analysis - Lindy Conner

    Chapter 5 Literary Analysis . HS English . ... Foreshadowing Repetition Foreboding Words . Slow Revelation of Details Expressive Imagery . ... Use a thesaurus or synonym finder to help find different words for the same thought, Plot Summary .
  • Measuring GP Opening Hours A presentation for Welsh

    Measuring GP Opening Hours A presentation for Welsh

    Measuring GP Opening Hours A presentation for Welsh Health Analysts Network (WHAN) Kim Swain Health, Social Services and Children Analytical Team
  • THE VALUE and sanctity OF LIFE - australiaforchrist.church

    THE VALUE and sanctity OF LIFE - australiaforchrist.church

    Genesis 1 - 26 Then God said, o "Let us make man 8 in our image, p after our likeness. And q let them have dominion over the fish of the sea and over the birds of the heavens and...
  • thing of the month The Disney Princess of

    thing of the month The Disney Princess of

    A Fairy tale and a cartoon. Snow White is a cartoon character. Sheis a Princessof great beauty who has a stepmother. Herstepmotheris a Queenand shewantsto kill Snow white becausesheis more beautifulthan the Queen.